Article
A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency.
British journal of cancer - 1 Sept 2020
Pallet Nicolas, Hamdane Salma, Garinet Simon, Blons Hélène, Zaanan Aziz, Paillaud Elena, Taieb Julien, Laprevote Olivier, Loriot Marie-Anne, Narjoz Céline
Abstract excerpt
BACKGROUND: Pretherapeutic screening for dihydropyrimidine dehydrogenase (DPD) deficiency is recommended or required prior to the administration of fluoropyrimidine-based chemotherapy. However, the best strategy to identify DPD-deficient patients remains elusive. METHODS: Among a nationwide cohort of 5886 phenotyped patients with cancer who were screened for DPD deficiency over a 3 years period, we assessed the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
